Evidence map›Paper›PMID 18069898›Full record

ArticlePLoS genetics2007

A mechanism misregulating p27 in tumors discovered in a functional genomic screen.

Carrie M Garrett-Engele, Michael A Tasch, Harry C Hwang, Matthew L Fero, Roger M Perlmutter, Bruce E Clurman, James M Roberts

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The miR-106a~363Oncotarget · 2017
    Article
  6. Rp58 and p27Neural development · 2017
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Carrie M Garrett-EngeleDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Michael A Tasch
Harry C Hwang
Matthew L Fero
Roger M Perlmutter
Bruce E Clurman
James M Roberts
Fred Hutch Cancer Center · USHoward Hughes Medical Institute · USUniversity of Washington · US

Funding

Cell Autonomy and Tumor Suppression by CDK inhibitorsR01CA100053 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI FERO, MATTHEW L · 2005 to 2009
$1.7M
p27 regulators isolated in a functional genomics assayF32CA094655 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GARRETT-ENGELE, CARRIE M · 2003 to 2005
$152k
NCI NIH HHS 5T32CA0947NCI NIH HHS CA094655NCI NIH HHS F32 CA094655NCI NIH HHS R01 CA100053
6 · The paper itself

Abstract

The cyclin-dependent kinase inhibitor p27(KIP1) is a tumor suppressor gene in mice, and loss of p27 protein is a negative prognostic indicator in human cancers. Unlike other tumor suppressors, the p27 gene is rarely mutated in tumors. Therefore misregulation of p27, rather than loss of the gene, is responsible for tumor-associated decreases in p27 protein levels. We performed a functional genomic screen in p27(+/-) mice to identify genes that regulate p27 during lymphomagenesis. This study demonstrated that decreased p27 expression in tumors resulted from altered transcription of the p27 gene, and the retroviral tagging strategy enabled us to pinpoint relevant transcription factors. inhibitor of DNA binding 3 (Id3) was isolated and validated as a transcriptional repressor of p27. We further demonstrated that p27 was a downstream target of Id3 in src-family kinase Lck-driven thymic lymphomagenesis and that p27 was an essential regulator of Lck-dependent thymic maturation during normal T-cell development. Thus, we have identified and characterized transcriptional repression of p27 by Id3 as a new mechanism decreasing p27 protein in tumors.

Indexed as

AnimalsBase SequenceCell DifferentiationCell Line, TumorCyclin-Dependent Kinase Inhibitor p27FemaleGene Expression Regulation, NeoplasticHumansInhibitor of Differentiation ProteinsLymphocyte Specific Protein Tyrosine Kinase p56(lck)LymphomaMaleMiceMice, Inbred C57BLMice, KnockoutMice, Mutant StrainsCdkn1b protein, mouseCyclin-Dependent Kinase Inhibitor p27Idb3 protein, mouseInhibitor of Differentiation ProteinsLymphocyte Specific Protein Tyrosine Kinase p56(lck)RNA, MessengerRNA, NeoplasmRNA, Small Interfering

Identifiers

PMID18069898
PMCPMC2134944
OpenAlexW2059563600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.